Nothing Special   »   [go: up one dir, main page]

CA3158673A1 - Compositions pharmaceutiques comprenant des anions cannabinoides - Google Patents

Compositions pharmaceutiques comprenant des anions cannabinoides Download PDF

Info

Publication number
CA3158673A1
CA3158673A1 CA3158673A CA3158673A CA3158673A1 CA 3158673 A1 CA3158673 A1 CA 3158673A1 CA 3158673 A CA3158673 A CA 3158673A CA 3158673 A CA3158673 A CA 3158673A CA 3158673 A1 CA3158673 A1 CA 3158673A1
Authority
CA
Canada
Prior art keywords
composition
health condition
cancer
cannabinoid
anion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3158673A
Other languages
English (en)
Inventor
Douglas G. Metcalf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Natural Extraction Systems LLC
Original Assignee
Metcalf Douglas G
Natural Extraction Systems LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metcalf Douglas G, Natural Extraction Systems LLC filed Critical Metcalf Douglas G
Publication of CA3158673A1 publication Critical patent/CA3158673A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Divers aspects de ce document de brevet concernent des compositions pharmaceutiques comprenant des anions cannabinoïdes destinés à être utilisés en tant que médicaments et des compositions comprenant des anions cannabinoïdes destinées à être utilisées pour fabriquer de tels médicaments.
CA3158673A 2019-11-14 2020-11-13 Compositions pharmaceutiques comprenant des anions cannabinoides Pending CA3158673A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962935496P 2019-11-14 2019-11-14
US62/935,496 2019-11-14
US202062969614P 2020-02-03 2020-02-03
US62/969,614 2020-02-03
PCT/US2020/060345 WO2021097163A1 (fr) 2019-11-14 2020-11-13 Compositions pharmaceutiques comprenant des anions cannabinoïdes

Publications (1)

Publication Number Publication Date
CA3158673A1 true CA3158673A1 (fr) 2021-05-20

Family

ID=75912885

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3158673A Pending CA3158673A1 (fr) 2019-11-14 2020-11-13 Compositions pharmaceutiques comprenant des anions cannabinoides

Country Status (2)

Country Link
CA (1) CA3158673A1 (fr)
WO (1) WO2021097163A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20207105B (en) * 2015-07-31 2020-05-11 Pfizer 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
US20190030170A1 (en) * 2016-05-10 2019-01-31 Vireo Health LLC Cannabinoid formulations with improved solubility
ES2638057B1 (es) * 2017-03-02 2018-10-01 Universidad Del País Vasco / Euskal Herriko Unibertsitatea Tratamiento de la demencia con agonistas cannabinoides

Also Published As

Publication number Publication date
WO2021097163A1 (fr) 2021-05-20

Similar Documents

Publication Publication Date Title
US20230293458A1 (en) Multibiotic agents and methods of using the same
US11512087B2 (en) BRK inhibitory compound
US11767301B2 (en) Bi-functional molecules to degrade circulating proteins
US9284283B2 (en) Macrocyclic compounds for modulating IL-17
US11339136B2 (en) Compounds and compositions for treating conditions associated with NLRP activity
CN101815716B (zh) 作为11-β羟基类固醇脱氢酶1型的抑制剂的螺环
US20210145974A1 (en) Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins
CN104334526A (zh) 异吲哚酮衍生物
CA2947031C (fr) Composes et compositions d'induction de la chondrogenese
US9890146B2 (en) Compound having selective EP2 agonist activity
US11866422B2 (en) Carbocyclic prolinamide derivatives
US20240050578A1 (en) Bi-functional molecules to degrade circulating proteins
CN104011048A (zh) 作为磷酸二酯酶抑制剂的[1,2,4]三唑并吡啶类化合物及其应用
CA3158673A1 (fr) Compositions pharmaceutiques comprenant des anions cannabinoides
JP5205266B2 (ja) 細胞遊走調節化合物
WO2021097150A1 (fr) Méthodes de prévention et de traitement de problèmes de santé à l'aide d'anions cannabinoïdes
WO2005005366A1 (fr) Compose d'acide carboxylique ramifie et utilisation de ce compose
CN1382146A (zh) 作为磷酸二酯酶vii抑制剂的咪唑衍生物
TWI537245B (zh) 用於治療自體免疫發炎疾病之化合物
WO2007033192A1 (fr) Sels salicylate et gentisate d'un compose piperazine
WO2022173812A1 (fr) Compositions et procédés associés à des anions cannabinoïdes
JP2012097003A (ja) ビキシン誘導体及び細胞保護剤
WO2022026960A1 (fr) Compositions et procédés associés à des excipients et des formulations de cannabinoïdes
US20240131040A1 (en) Compositions and methods related to cannabinoid anions
MX2010013301A (es) Nuevos terpenos y macrociclos.